ArticleBlood cancer journal2025

Cardiovascular adverse events and outcomes after anti-BCMA CAR-T for relapsed and refractory multiple myeloma.

Stefanie Palfi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.